Involvement of basal ganglia transmitter systems in movement initiation

Progress in Neurobiology

Volumn 56, Issue 5, 1998, Pages 507-540

  Hauber, Wolfgang ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADENOSINE; DOPAMINE; GLUTAMIC ACID; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BASAL GANGLION; CORPUS STRIATUM; ENTOPEDUNCULAR NUCLEUS; FUNCTIONAL ANATOMY; GLOBUS PALLIDUS; MOTOR PERFORMANCE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RETICULAR FORMATION; REVIEW; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; BASAL GANGLIA; CEREBRAL CORTEX; HUMANS; MODELS, NEUROLOGICAL; MOVEMENT; MOVEMENT DISORDERS; NEUROTRANSMITTER AGENTS; PSYCHOMOTOR PERFORMANCE; RATS; THALAMUS;

EID: 0031680185     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00041-0     Document Type: Review

References (364)

1. Ahlenius S., Hillegaart V., Thorell G., Magnusson O., Fowler C. J. Suppression of exploratory locomotor activity and increase in dopamine turnover following the local application of cis-flupenthixol into limbic projection areas of the rat striatum. Brain Res. 402:1987;131-138.
2. Alamy M., Trouche E., Nieoullon A., Legallet E. Globus pallidus and motor initiation: the bilateral effects of unilateral quisqualic acid-induced lesion on reaction times in monkeys. Exp. Brain Res. 99:1994;247-258.
3. Albin R. L., Young A. B., Penney J. B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
4. Albin R. L., Marcowiec R. L., Hollingsworth Z. R., Dure L. S., Penney J. B., Young A. B. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46:1992;35-48.
5. Alexander G. E., DeLong M. R., Strick P. L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann. Rev. Neurosci. 9:1986;357-381.
6. Amalric M., Koob G. F. Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. J. Neurosci. 7:1987;2129-2134.
7. Amalric M., Koob G. F. Dorsal pallidum as a functional motor output of the corpus striatum. Brain Res. 483:1989;389-394.
8. Amalric M., Berhow M., Polis I., Koob G. F. Selective effects of low-dose D2 dopamine receptor antagonism in a reaction-time task in rats. Neuropsychopharmacology. 8:1993;195-200.
9. Amalric M., Farin D., Dormont J. F., Schmied A. GABA-receptor activation in the globus pallidus and entopeduncular nucleus: opposite effects on reaction time performance in the cat. Exp. Brain Res. 102:1994;244-258.
10. Amalric M., Ouagazzal A., Baunez C., Nieoullon A. Functional interactions between glutamate and dopamine in the rat striatum. Neurochem. Int. 25:1994;123-131.
11. Amalric M., Moukhles H., Nieoullon A., Daszuta A. Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat. Eur. J. Neurosci. 7:1995;972-980.
12. Amato G., Trouche E., Beaubaton D., Grangetto A. The role of internal pallidal segment on the initiation of a goal directed movement. Neurosci. Lett. 9:1978;159-163.
13. 2 agonist-induced rotation in 6-hydroxydopamine-lesioned rats. Brain Res. 588:1992;307-310.
14. Anderson J. J., Randall S., Chase T. N. The neurokinin(1) receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D-2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum. J. Pharmac. Exp. Ther. 274:1995;928-936.
15. Apicella P., Trouche E., Nieoullon A., Legallet E., Dusticier N. Motor impairments and neurochemical changes after unilateral 6-hydroxydopamine lesions of the nigrostriatal dopaminergic system in monkeys. Neuroscience. 38:1990;655-666.
16. Apicella P., Legallet E., Nieoullon A., Trouche E. Neglect of contralateral visual stimuli in monkeys with unilateral striatal dopamine depletion. Behav. Brain Res. 46:1991;187-196.
17. Apicella P., Legallet E., Nieoullon A., Trouche E. Quantitative behavioral study of the acute and long-term effects of two-stage bilateral 6-OHDA-induced lesions of the nigrostriatal dopaminergic system in monkeys. Behav. Neurosci. 109:1995;329-341.
18. Arnt J., Christensen A. V. Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics. Eur. J. Pharmac. 69:1981;107-111.
19. Arnt J., Scheel-Krüger J. Intranigral GABA antagonists produce dopamine-independent biting in rats. Eur. J. Pharmac. 62:1980;51-61.
20. Asin K. E., Wirtshafter D., Fibiger H. C. Alterations in drug-induced catalepsy and post-decapitation convulsions following brain and spinal cord depletion of norepinephrine by the neurotoxin DSP-4. Life Sci. 3:1982;1531-1536.
21. Aston-Jones, G., Shipley, M. T. and Grzanna, R. (1995) The locus coeruleus, A5 and A7 noradrenergic cell groups. In: The Rat Nervous System, pp. 183-213. Ed. G. Paxinos. Academic Press, San Diego.
22. Avdelidis D., Spyraki C. Dopamine-dependent behaviours in rats with bilateral ibotenic acid-induced lesions of the globus pallidus. Brain Res. Bull. 16:1986;25-32.
23. Bankiewicz K. S., Oldfield E. H., Plunkett R. J., Schuette W. H., Cogan D. G., Hogan N., Zuddas A., Kopin I. J. Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion. Brain Res. 541:1991;98-102.
24. Baunez C., Amalric M. Evidence for functional differences between entodeduncular nucleus and substantia nigra: effects of APV (DL-2-amino-phosphonovaleric acid) microinfusion on reaction time performance in the rat. Eur. J. Neurosci. 8:1996;1972-1982.
25. Baunez C., Nieoullon A., Amalric M. N-Methyl-D-aspartate receptor blockade impairs behavioural performance of rats in a reaction time task: new evidence for glutamatergic-dopaminergic interactions in the striatum. Neuroscience. 61:1994;521-531.
26. Baunez C., Nieoullon A., Amalric A. Dopamine and complex sensorimotor integration: further studies in a conditioned motor task in the rat. Neuroscience. 65:1995;375-384.
27. Baunez C., Nieoullon A., Amalric M. In a rat model of Parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. J. Neurosci. 15:1995;6531-6541.
28. Beckstead R. M. Complementary mosaic distributions of thalamic and nigral axons in the caudate nucleus of the cat: double anterograde labeling combining autoradiography and wheat germ-HRP histochemistry. Brain Res. 335:1985;153-159.
29. Beckstead R. M., Domesick V. B., Nauta W. J. H. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175:1979;191-217.
30. Berretta S., Parthasarathy H. B., Graybiel A. M. Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J. Neurosci. 17:1997;4752-4763.
31. Bevan M. D., Crossman A. R., Bolam J. P. Neurons projecting from the entopeduncular nucleus to the thalamus receive convergent synaptic inputs from the subthalamic nucleus and the neostriatum in the rat. Brain Res. 659:1994;99-109.
32. Bevan M. D., Smith A. D., Bolam J. P. The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat. Neuroscience. 75:1996;5-12.
33. Biggs C. S. F. L. J., Whitton P. S., Starr M. S. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats. Eur. J. Pharmac. 299:1996;83-91.
34. Bolam J. P., Smith Y., Ingham C. A., Von Krosigk M., Smith A. D. Convergence of synaptic terminals from the striatum and the globus pallidus onto single neurones in the substantia nigra and the entopeduncular nucleus. Progr. Brain Res. 99:1993;73-88.
35. Boldry R. C., Chase T. N., Engber T. M. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions. J. Pharmacol. Exp. Ther. 267:1993;1454-1459.
36. Brockel B. J., Fowler S. C. Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine. J. Pharmac. Exp. Ther. 275:1995;1090-1098.
37. 2 receptor blockade project to the globus pallidus. Neuroscience. 74:1996;805-812.
38. Brotchie J. M., Mitchell I. J., Sambrook M. A., Crossman A. R. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov. Disord. 6:1991;133-138.
39. 2a purine receptors regulate striatal acetylcholine release. J. Neurochem. 55:1990;31-38.
40. Brown V. J., Bowman E. M. Discriminative cues indicating reward magnitude continue to determine reaction time of rats following lesions of the nucleus accumbens. Eur. J. Neurosci. 7:1995;2479-2485.
41. Brown V. J., Robbins T. W. Simple and choice reaction time performance following unilateral striatal dopamine depletion in the rat. Brain. 114:1991;513-525.
42. Brown V. J., Brasted P. J., Bowman E. M. The effect of systemic D-amphetamine on motor versus motivational processes in the rat. Psychopharmacology. 128:1996;171-180.
43. Bubser M., Tschentke T., Hauber W. Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats. J. Neural. Transm. 101:1994;115-126.
44. Burns L. H., Sato K., Wüllner U., Isacson O. Intra-nigra infusion of AMPA attenuates dopamine-dependent rotation in the rat. Neuroreport. 4:1993;1075-1078.
45. 2-dopamine receptor-mediated catalepsy. Brain Res. 450:1988;403-407.
46. Camarata P. J., Parker R. G., Park S. K., Haines S. J., Turner D. A., Chae H., Ebner T. J. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced hemiparkinsonism on the kinematics of a two-dimensional, multijoint arm movement in the rhesus monkey. Neuroscience. 48:1992;607-619.
47. 1 receptors facilitate transmitter release. Nature. 366:1993;344-347.
48. Canteras N. S., Shammah-Lagnado S. J., Silva B. A., Ricardo J. A. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513:1990;43-59.
49. Carli M., Samanin R. Serotonin 2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacology. 106:1992;228-234.
50. Carli M., Robbins T. W., Evenden J. L., Everitt B. J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Res. 9:1983;361-380.
51. Carli M., Evenden J. L., Robbins T. W. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature. 313:1985;679.
52. Carli M., Jones G. H., Robbins T. W. Effects of unilateral dorsal and ventral striatal dopamine depletion on visual neglect in the rat: a neural and behavioural analysis. Neuroscience. 29:1989;309-327.
53. Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmac. Rev. 11:1959;490-493.
54. Carlsson M., Carlsson A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural. Transm. 75:1989;221-226.
55. Carlsson M., Svensson A. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmac. Biochem. Behav. 36:1990;45-50.
56. Carlsson M., Svensson A. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Sci. 47:1990;1729-1736.
57. Carlsson M. L. Are the disparate pharmacological profiles of competitive and non-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? J. Neural Transm. 94:1993;1-10.
58. Carroll C. B., Holloway V., Brotchie J. M., Mitchell I. J. Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms. Psychopharmacology (Berlin). 119:1995;55-65.
59. Carter C. J., Pycock C. J. A study of the sites of interaction between dopamine and 5-hydroxytryptamine for the production of fluphenazine-induced catalepsy. Naunyn-Schmiedeberg's Arch. Pharmac. 304:1978;135-139.
60. Carter D. A., Fibiger H. C. The projections of the entopeduncular nucleus and globus pallidus in rat as demonstrated by autoradiography and horseradish peroxidase histochemistry. J. Comp. Neurol. 177:1978;113-124.
61. Casas M., Ferre S., Guix T., Jane F. Theophylline reverses haloperidol-induced catalepsy in the rat. Biol. Psychiat. 24:1988;642-648.
62. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542.
63. Chergui K., Charléty P. J., Akaoka H., Saunier C. F., Brunet J. L., Buda M., Svensson T. H., Chovet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5:1993;137-144.
64. Chesselet M.-F., Delfs J. M. Basal ganglia and movement disorders: an update. Trends Neurosci. 19:1996;417-422.
65. Chevalier G., Deniau J. M. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci. 13:1990;277-280.
66. Christoffersen C. L., Meltzer L. T. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neuroscience. 67:1995;373-381.
67. Clineschmidt B. V., Martin G. E., Bunting P. R., Papp N. L. Central sympathomimetic activity of MK-801, a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev. Res. 2:1982;135-145.
68. Cole B. J., Robbins T. W. Forebrain norepinephrine: role in controlled information processing in the rat. Neuropsychopharmacology. 7:1992;129-142.
69. Colpaert F. C. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology. 26:1987;1431-1440.
70. Cools A. R. The transsynaptic relationship between dopamine and serotonin in the caudate nucleus of cats. Psychopharmacologia. 36:1974;229-237.
71. Cools A. R., Jaspers R., Kolasiewicz W., Sontag K.-H., Wolfarth S. Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons. Behav. Brain Res. 7:1983;39-49.
72. Cools, A. R., Jaspers, R., Schwarz, M., Sontag, K.-H., Vrijmoed-de Vries, M. and Van den Berken, J. (1984) Basal ganglia and switching motor programs. In: The Basal Ganglia. Structure and Function, Eds. J. McKenzie, W. Klemm and J. Wilcox, J. Plenum Press, New York.
73. Costall B., Naylor R. J. Neuroleptic and non-neuroleptic catalepsy. Arzneim.-Forsch. (Drug Res.). 23:1973;674-683.
74. Costall B., Olley J. E. Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra. Neuropharmacology. 10:1971;581-594.
75. Costall B., Naylor R. J., Olley J. E. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology. 11:1972;645-663.
76. Costall B., Fortune D. H., Naylor R. J., Marsden C. D., Pycock C. Serotonergic involvement with neuroleptic catalepsy. Neuropharmacology. 14:1975;859-868.
77. Cousins M. S., Sokolowski J. D., Salamone J. D. Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol. Biochem. Behav. 46:1993;943-951.
78. Cousins M. S., Salamone J. D. Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization. Brain Res. 732:1996;186-194.
79. Creese I., Iversen S. D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83:1975;419-436.
80. Crossman A. R. Primate models of dyskinesia: the experimental approach to the study of basal ganglia related involuntary movement disorders. Neuroscience. 21:1987;1-40.
81. De Long M. R., Coyle J. T. Globus pallidus lesions in the monkey produced by kainic acid: histologic and behavioral effects. Appl. Neurophysiol. 42:1979;95-97.
82. De Montis G. M., Olianas M. C., Serra G., Tagliamonte A., Scheel-Krüger J. Evidence that a nigral GABA-ergic-cholinergic balance controls posture. Eur. J. Pharmac. 53:1979;181-190.
83. De Ryck M., Schallert T. M., Teitelbaum P. Morphine versus haloperidol catalepsy in the rat: a behavioral analysis of postural support mechanisms. Brain Res. 201:1980;143-172.
84. De Vito J. L., Anderson M. E. An autoradiographic study of efferent connections of the globus pallidus in macaca mulatta. Exp. Brain Res. 46:1982;107-117.
85. De Vito J. L., Anderson M. E., Walsh K. E. A horseradish peroxidase study of afferent connections of the globus pallidus in macaca mulatta. Exp. Brain Res. 33:1980;65-73.
86. Deniau J. M., Chevalier G. The lamellar organization of the rat substantia nigra pars reticulata: distribution of projection neurons. Neuroscience. 46:1992;361-377.
87. Deniau J. M., Hammon C., Riszk A., Feger J. Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): evidence for the existence of branched neurons. Exp. Brain Res. 32:1978;409-422.
88. Deniau J. M., Menetrey A., Thierry A. M. Indirect nucleus accumbens input to the prefrontal cortex via the substantia nigra pars reticulata: a combined anatomical and electrophysiological study in the rat. Neuroscience. 61:1994;533-545.
89. Denny-Brown, D. and Yanagisawa, N. (1976) The role of the basal ganglia in the initiation of movement. In: The Basal Ganglia, Ed. M. Yahr. Raven Press, New York.
90. Di Chiara, G., Porceddu, M. L., Imperato, A. and Morelli, M. (1981) Role of GABA neurons in the expression of striatal motor functions. In: Adv. Biochem. Psychopharmacol.: GABA and the Basal ganglia. Eds. G. DiChiara and G. L. Gessa. Raven Press, New York.
91. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17:1994;228-233.
92. Dunnett S. B., Björklund A. Conditioned turning in rats: dopaminergic involvement in the initiation of movement rather than the movement itself. Neurosci. Lett. 41:1983;173-178.
93. Elliott P. J., Close S. P., Walsh D. M., Hayes A. G., Marriott A. S. Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists. J. Neural. Transm. 2:1990;91-100.
94. Engber T. M., Anderson J. J., Boldry R. C., Papa S. M., Kuo S., Chase T. N. Excitatrory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats. Neuroscience. 2:1994;389-399.
95. Engber T. M., Papa S. M., Boldry R. C., Chase T. N. NMDA receptor blockade reverses motor response alterations induced by levodopa. Neuroreport. 5:1994;2586-2588.
96. Evarts E. V., Teräväinen H., Calne D. B. Reaction time in Parkinson's disease. Brain. 104:1981;167-186.
97. Fallon, J. H. and Loughlin, S. E. (1995) Substantia nigra. In: The Rat Nervous System, pp. 215-237. Ed. G. Paxinos. Academic Press, San Diego.
98. Féger, J. (1981) Electrophysiological studies of GABA-ergic neurons in the basal ganglia: Nigro-collicular, nigro-thalamic and palido-subthalamic neurons. In: Adv. Biochem. Psychopharmacol.: GABA and the Basal Ganglia. Eds. G. DiChiara and G. L. Gessa. Raven Press, New York.
99. Féger J. Updating the functional model of the basal ganglia. Trends Neurosci. 20:1997;152-153.
100. Féger J., Robledo P. The effects of activation or inhibition of the subthalamic nucleus on the metabolic and electrophysiological activities within the pallidal complex and substantia nigra in the rat. Eur. J. Neurosci. 3:1991;947-952.
101. Féger, J., Robledo, P. and Renwart, N. (1991) The subthalamic nucleus: new data, new questions. In: The Basal Ganglia III. Ed. G. Bernardi. Plenum Press, New York.
102. Féger J., Bevan M., Crossman A. R. The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: a comparison with the corticostriatal and corticosubthalamic efferents in a retrograde fluorescent double-labelling study. Neuroscience. 60:1994;125-132.
103. Ferguson S. A., Paule M. G. Acute effects of chlorpromazine in a monkey operant behavioral test battery. Pharmac. Biochem. Behav. 42:1992;333-341.
104. Ferré S., Rubio A., Fuxe K. Stimulation of adenosine A2 receptors induces catalepsy. Neurosci. Lett. 130:1991;162-164.
105. Ferré S., O'Connor W. T., Fuxe K., Ungerstedt U. The striopallidal neuron - a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13:1993;5402-5406.
106. Ferré S., Popoli P., Giménez-Llort L., Finnman U.-B., Martínez E., Scotti de Carolis A., Fuxe K. Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. NeuroReport. 6:1994;73-76.
107. Ferré S., O'Connor W., Svenningsson P., Björklund L., Lindberg L., Tinner B., Strömberg I., Goldstein M., Ögren S., Ungerstedt U., Fredholm B. B., Fuxe K. Dopamine D1 receptor-mediated transmission in the rat strioentodeduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur. J. Neurosci. 8:1996;1545-1553.
108. Ferré S., Popoli P., Tinner-Staines B., Fuxe K. Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites. Neurosci. Lett. 208:1996;109-112.
109. Flowers K. A. Visual "closed-loop" and "open-loop" characteristics of voluntary movement in patients with parkinsonism and intention tremor. Brain. 99:1976;269-310.
110. Fonnum F., Gottesfeld Z., Grofova I. Distribution of glutamate decarboxylase, choline acetyltransferase and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular and striatonigral GABAergic fibres. Brain Res. 143:1978;125-138.
111. Fowler S. C. Effects of pimozide on emitted force, duration and rate of operant response maintained at low and high levels of required force. Pharmac. Biochem. Behav. 25:1986;615-622.
112. Fowler S. C., Liou J. R. Microcatalepsy and disruption of forelimb usage during operant behavior: differences between dopamine D-1 (SCH-23390) and D-2 (raclopride) antagonists. Psychopharmacology. 115:1994;24-30.
113. Fowler S. C., Mortell C. Low doses of haloperidol interfere with rat tongue extensions during licking - a quantitative analysis. Behav. Neurosci. 106:1992;386-395.
114. Fredriksson A., Gentsch C., Archer T. Effect of the competitive NMDA antagonist, CGP 40 116, and a low dose of L-dopa on the motor activity deficit of MPTP-treated mice. Behav. Pharmac. 5:1994;599-606.
115. Fredriksson A., Gentsch C., Archer T. Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice. J. Neural. Transm. 97:1994;197-209.
116. 1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. natl Acad. Sci. U.S.A. 88:1991;3772-3776.
117. Fujimoto K., Kita H. Response characteristics of subthalamic neurons to the stimulation of the sensorimotor cortex in the rat. Brain Res. 609:1993;185-192.
118. Fuxe K., Cintra A., Agnati L. F., Härfstrand A., Golstein M. Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic AMP-immunoreactive neuronal structures and D1 receptor antagonist binding sites in various brain regions of the male rat-mismatches indicate a role of D1 receptors in volume transmission. Neurochem. Int. 13:1988;179-197.
119. Fuxe, J., Ferré, S., Dasgupta, S., O'Connor, W. T., Snaprud, P., Arenas, E., Persson, H., Ungerstedt, U. and Fredholm, B. (1995) Evidence for the existence of antagonistic intramembrane adenosine A2a/dopamine D2 receptor interactions in the basal ganglia: analysis from the network to the molecular level. In: Adenosine and Adenine Nucleotides: from Molecular Biology to Integrative Physiology, pp. 499-507, Eds. L. Bellardinelli and A. Pelleg. Klüver Academic, Boston.
120. Gabay, S. (1981) Serotonergic-dopaminergic interactions: implications for hyperkinetic disorders. In: Serotonin: Current Aspects of Neurochemistry and Function, Eds. B. Haber, S. Gabay, M. R. Issidorides and S. G. A. Alvisatos. Plenum Press, London.
121. Galvn A., Floran L., Floran B., Sierra A., Aceves J. D2 receptor-mediated inhibition of the release of GABA by endogenous dopamine in the rat globus pallidus. Soc. Neurosci. Abstr. 292:1997;16.
122. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchack P. A., Collins F., Hoffer B. J., Gerhardt G. A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
123. Gerfen C. F. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
124. Gerfen, C. R. and Wilson, C. J. (1996) The Basal Ganglia. Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam.
125. Gerfen C. R., Staines W. A., Arbuthnott G. W., Fibiger H. D. Crossed connections of the substantia nigra in the rat. J. Comp. Neurol. 207:1982;283-303.
126. 2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on seperate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
127. Goddwin P., Starr B. S., Starr M. S. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK-801. J. Neural. Transm. 4:1992;15-26.
128. Góngora-Alfaro J. L., Hernández-López S., Martínez-Fong D., Brassart J.-L., Aceves J. Activation of nigral M1 and M2 muscarinic receptors produces opposing effects on striatal 3,4-dihydro-xyphenylacetic acid measured by in vivo voltametry. Brain Res. 554:1991;329-332.
129. Graybiel A. M. The basal ganglia and the initiation of movement. Rev. Neurol. (Paris). 146:1990;570-574.
130. Graybiel A. M., Aosaki T., Flaherty A. W., Kumura M. The basal ganglia and adaptive motor control. Science. 265:1994;1826-1831.
131. Greenamyre J. T. Actions of glutamate antagonists in the MPTP primate model of Parkinson's disease. Eur. J. Neurosci. 5(Suppl.):1992;238.
132. Groenewegen H. J., Berendse H. W., Haber S. N. Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience. 57:1993;113-142.
133. Groenewegen, H. J., Wright, C. I. and Beijer, A. V. J. (1996) The nucleus accumbens: gateway for limbic structures to reach the motor system? In: Emotional Motor System, Vol. 107, pp. 485-511. Eds. G. Holstege, R. Bandler and C. B. Saper. Elsevier Science, Amsterdam.
134. Grofová I. The idendification of striatal and pallidal neurons projecting to substantia nigra. An experimental study by means of retrograde axonal transport of horseradish peroxidase. Brain Res. 91:1975;286-291.
135. Guo N., Robertson G. S., Fibiger H. C. Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res. 588:1992;164-167.
136. Hallett M. Clinical neurophysiology of akinesia. Rev. Neurol. (Paris). 146:1990;585-590.
137. Hallett M., Khoshbin S. A physiological mechanism of bradykinesia. Brain. 101:1980;35-52.
138. Halliday, G., Harding, A. and Paxinos, G. (1995) Serotonin and tachykinin systems. In: The Rat Nervous System, Vol. 34, pp. 929-974. Ed. G. Paxinos. Academic Press, San Diego.
139. Hamada I., DeLong M. R. Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J. Neurophysiol. 68:1992;1850-1858.
140. Hamada I., DeLong M. R. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J. Neurophysiol. 68:1992;1859-1866.
141. Hammond C., Deniau J. M., Rizk A., Féger J. Electrophysiological demonstration of an excitatory subthalamonigral pathway in the rat. Brain Res. 151:1978;235-244.
142. Harrison A. A., Muir J. L., Robbins T. W., Everitt B. J., Wilkinson L. S. Enhanced inpulsivity and distractibility in tests of visual attention in rats with forebrain serotonin depletion. Soc. Neurosci. Abstr. 19:1993;244.8.
143. Hassani O.-K., Mouroux M., Féger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 72:1996;105-115.
144. Hassani O. K., Francois C., Yelnik J., Feger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749:1997;88-94.
145. Hauber W. Dizocilpine-induced delayed alternation impairment is improved by clozapine. J. Neural Transm. 94:1993;233-243.
146. 2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors. Neuroscience. 73:1996;121-130.
147. Hauber W., Andersen R. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anti-cataleptic activity induced by the NMDA antagonist dizocilpine. Naunyn-Schmiedeberg's Arch. Pharmac. 348:1993;486-490.
148. 2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors. Neurosci. Lett. 196:1995;205-208.
149. Hauber W., Münkle M. Anti-cataleptic effects of the adenosine receptor antagonist theophylline. Naunyn-Schmiedeberg's Arch. Pharmac. 354:1996;179-186.
150. Hauber W., Münkle M. Motor depressant effects mediated by dopamine D2 and adenosine A2a receptors in the nucleus accumbens and the caudate-putamen. Eur. J. Pharmac. 323:1997;127-131.
151. Hauber W., Schmidt W. J. Effects of intrastriatal blockade of glutamatergic transmission on the acquisition of T-maze and radial maze tasks. J. Neural Transm. 78:1989;29-41.
152. Hauber W., Schmidt W. J. Acquisition, but not retrieval of delayed alternation is impaired by ketamine. Res. Comm. Psychol. Psychiat. Behav. 5:1990;17-29.
153. Hauber W., Schmidt W. J. The NMDA antagonist dizocilpine reverses haloperidol-induced movement initiation deficits. Behav. Brain Res. 41:1990;161-166.
154. Hauber W., Schmidt W. J. Discrete quinolinic acid lesions of the lateral but not of the medial caudate-putamen reversed haloperidol-induced catalepsy in rats. J. Neural. Transm. 94:1993;103-114.
155. Hauber W., Waldenmeier M.-T. The AMPA antagonist GYKI 52466 reverses the anticataleptic effects of the competitive NMDA receptor antgaonists CGP 37849. Eur. J. Pharmac. 256:1994;339-342.
156. Hauber W., Bubser M., Schmidt W. J. 6-Hydroxydopamine lesion of the rat prefrontal cortex impairs motor initiation but not motor execution. Exp. Brain Res. 99:1994;524-528.
157. Hauber, W., Lutz, S. and Hessel, M. (1997) Blockade of dopamine D1 or D2 receptors in the globus pallidus induced akinesia in rats. Soc. Neurosci. Abstr. 80.4.
158. Hauber, W., Lutz, S. and Münkle, M. (1998a) The effects of globus pallidus-lesions on dopamine-dependent motor behaviour in rats. Neuroscience, 86, 147-157.
159. Hauber, W., Nagel, J., Sauer, R. and Müller, C.E. (1998b) Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen. Neuroreport, 9, 1803-1806.
160. Heimer, L., Zahm, D. S. and Alheid, G. F. (1995) Basal ganglia. In: The Rat Nervous System, pp. 579-628. Ed. G. Paxinos. Academic Press, San Diego.
161. Herkenham M., Nauta W. J. H. Afferent connections of the habenular nuclei in the rat: a horseradish peroxidase study, with a note on the fiber-of-passage problem. J. Comp. Neurol. 173:1977;123-146.
162. 2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15:1995;5222-5237.
163. Hesselink J. M. Exacerbation of Parkinson's disease by fluoxetine. Human Psychopharmac. 7:1992;411-412.
164. Hicks P. B. The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci. 47:1990;1609-1615.
165. Hienz R. D., Spear D. J., Bowers D. A. Effects of cocaine on simple reaction times and sensory thresholds in baboons. J. Exp. Animal Behav. 61:1994;231-246.
166. Hikosaka, O. (1994) Role of basal ganglia in control of innate movements, learned behaviour and cogbition-a hypothesis. In: The Basal Ganglia IV. Eds. G. Percheron, J. S. McKenzie and J. Feger. Plenum Press, New York.
167. Hikosaka O., Wurtz R. H. Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus. J. Neurophysiol. 53:1985;266-291.
168. Hikosaka O., Wurtz R. H. Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata. J. Neurophysiol. 53:1985;292-308.
169. Honma T., Fukushima H. Role of brain norepinephrine in neuroleptic-induced catalepsy in rats. Pharmac. Biochem. Behav. 7:1977;501-506.
170. Horak F. B., Anderson M. E. Influence of globus pallidus on arm movements in monkeys. I. Effects of kainic acid-induced lesions. J. Neurophysiol. 52:1984;290-304.
171. Hore J., Vilis T. Arm movement performance during reversible basal ganglia lesions in the monkey. Exp. Brain Res. 39:1980;217-228.
172. Imai H., Steindler D. A., Kitai S. T. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243:1986;363-380.
173. Jackson E. A., Kelly P. H. Effects of intranigral injections of dopamine agonists and antagonists, glycine, muscimol and N-methyl-DL-aspartate on locomotor acivity. Brain Res. Bull. 13:1984;309-317.
174. 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmac. Biochem. Behav. 42:1992;903-907.
175. Janucz C. A., Berman R. F. Adenosinergic modulation of the EEG and locomotor effects of the A2 agonist, CGS21680. Pharmac. Biochem. Behav. 45:1993;913-919.
176. Joel D., Weiner I. The organization of the basal ganglia-thalamocortical circuits: open interconnected rather than closed segregated. Neuroscience. 63:1994;363-379.
177. Jones D. N. C., Higgins G. A. Effect of scopolamine on visual attention in rats. Psychopharmacology. 120:1995;142-149.
178. 2 receptor interactions in animal models of schizophrenia. Eur. J. Pharmac. 295:1996;147-154.
179. Kalivas P. W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18:1993;75-113.
180. Kanazawa I., Emson P. C., Emson A. C. Evidence for the existence of substance P-containing fibers in the striato-nigral and pallido-nigral pathways in rat brain. Brain Res. 119:1977;447-453.
181. Kanda T., Shiozaki S., Shimada J., Suzuki F., Nakamura J. KF17837: a novel selective adenosine A(2A) receptor antagonist with anticataleptic activity. Eur. J. Pharmac. 256:1994;263-268.
182. Kannari K., Markstein R. Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice. J. Neural. Transm. 84:1991;211-220.
183. Kato M., Kimura M. Effects of reversible blockade of basal ganglia on a voluntary arm movement. J. Neurophysiol. 68:1992;1516-1534.
184. Kawaguchi Y., Wilson C. J., Augood S. J., Emson P. C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18:1995;527-535.
185. Kelley A. E. The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience. 7:1982;615-630.
186. Kelly P. H., Iversen S. D. Selective 6-OHDA destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmac. 40:1976;45-56.
187. Kemp J. M., Powell T. P. The structure of the caudate nucleus of the cat: light and electron microscopy. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 262:1971;383-401.
188. Ketai R. Interaction between fluoxetine and neuroleptics. Am. J. Psychiat. 150:1993;836-837.
189. Kilpatrick I. C., Starr M. S., Fletcher A., James T. A., MacLeod N. K. Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studies. Exp. Brain Res. 40:1980;45-54.
190. Kimura M. Role of basal ganglia in behavioral learning. Neurosci. Res. 22:1995;353-358.
191. Kincaid A. E., Penney J. J. B., Young A. B., Newman S. W. Evidence for a projection from the globus pallidus to the entopeduncular nucleus in the rat. Neurosci. Lett. 128:1991;121-125.
192. Kita H., Kitai S. T. Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J. Comp. Neurol. 260:1987;435-452.
193. Kita H., Kitai S. T. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res. 447:1988;346-352.
194. Kita H., Kitai S. T. Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res. 564:1991;296-305.
195. Kita H., Kitai S. T. The morphology of globus pallidus projection neurons in the rat - an intracellular staining study. Brain Res. 636:1994;308-319.
196. Kitai, S. T. and Kita, H. (1987) Anatomy and Physiology of the Subthalamic Nucleus: A Driving Force of the Basal Ganglia. Plenum Press, New York.
197. Klemm W. R. Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol. 32:1989;403-422.
198. Klockgether T., Turski L. NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann. Neurol. 28:1990;539-546.
199. Klockgether T., Turski L., Honoré T., Zhang Z., Gash D. M., Kurlan R., Greenamyre J. T. The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys. Ann. Neurol. 30:1991;717-723.
200. Kostowski W., Jerlicz M., Bidzinski A., Hauptmann M. Evidence for existence of two opposite noradrenergic brain systems controlling behaviour. Psychopharmacology. 59:1978;311-312.
201. Kreiss D. S., Mastropietro C. W., Rawji S. S., Walters J. R. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J. Neurosci. 17:1997;6807-6819.
202. Kurokawa M., Koga K., Kase H., Nakamura J., Kuwana Y. Adenosine A(2a) receptor-mediated modulation of striatal acetylcholine release in vivo. J. Neurochem. 66:1996;1882-1888.
203. La Hoste G. J., Marshall J. F. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists. Behav. Brain Res. 38:1990;233-242.
204. Lategan A. J., Mavridis M., Marien M., Colpaert F. The effects of locus coeruleus lesions on behaviours induced by putative D1 and D2 receptor agonists. Neurosci. Res. Commun. 5:1989;63-72.
205. 2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
206. Le Moine C., Normand E., Guitteny A. F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. natl Acad. Sci. U.S.A. 87:1990;230-234.
207. Limon, I. D., Martinez-Fong, D., Rosales, M., Nunez, A. and Aceves, J. (1997) Dopamine inhibits GABA and stimulates glutamate release in the rat globus pallidus. Soc. Neurosci. Abstr. 292.15.
208. Lindvall O., Björklund A. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res. 172:1979;169-173.
209. Ljungberg T., Apicella P., Schultz W. Responses of monkey dopamine neurons during learning of behavioural reactions. J. Neurophysiol. 67:1992;145-163.
210. Löschmann P.-A., Lange K. W., Kunow M., Rettig K.-J., Jähnig P., Honore T., Turski L., Wachtel H., Jenner P., Marsden C. D. Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. J. Neural. Transm. 3:1991;203-213.
211. Luquin M. R., Obeso J. A., Laguna J., Guillen J., Martinez-Lage J. M. The AMPA receptor antagonist NBQX does not alter the motor responsen induced by the selective dopamine agonists in MPTP treated monkeys. Eur. J. Pharmac. 235:1993;297-300.
212. Maj J., Rogoz Z., Skuza G., Sowinska H. The effect of the NMDA receptor anatgonists on neuroleptics-induced catalespsy in mice. Human Psychopharm. 8:1993;433-437.
213. Mally J., Stone T. W. The effect of theophylline on parkinson symptoms. J. Pharmac. Pharmacol. 46:1994;515-517.
214. Maneuf Y. P., Mitchell I. J., Crossman A. R., Brotchie J. M. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp. Neurol. 125:1994;65-71.
215. Maneuf Y., Mitchell I. J., Crossman A. R., Woodruff G. N., Brotchie J. M. Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease. Brain Res. 683:1995;102-108.
216. Marien, M., Lategan, A. and Colpaert, F. (1994) Noradrenergic control of striatal dopamine release. In: Noradrenergic Mechanisms in Parkinson's Disease, Vol. 9, pp. 139-158. Eds. M. Briley and M. Marien. CRC Press, Boca Raton.
217. Marrow L., Overton P., Clark D. Amelioration of some neuroletic-induced deficits by the NMDA antagonist MK-801 in a conditioned reaction time task. Behav. Pharmac. 3:1992;57-64.
218. Marrow L., Overton P., Clark D. Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat. Behav. Pharmac. 4:1993;15-28.
219. Marsden, C. D. (1984) Which motor disorder in Parkinson's disease indicates the true motor function of the basal ganglia? In: Functions of the Basal Ganglia. CIBA Symposium 107, Pitman, London.
220. Marsden C. D., Obeso J. A. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain. 117:1994;877-897.
221. Martin G. E., Rossi D. J., Jarvis M. F. Adenosine agonists reduce conditioned avoidance responding in rats. Pharmac. Biochem. Behav. 45:1993;951-958.
222. Mavridis M., Degryse A.-D., Lategan A. J., Marien M. R., Colpaert F. C. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after MPTP in monkeys: a possibles role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience. 41:1991;507-523.
223. Mayfield R. D., Randall P. K., Spirduso W. W., Wilcox R. E. The effects of systemically administered dopaminergic and brain regional GABA-ergic agonists and antagonists on reaction time response parameters in the rat. Soc. Neurosci. Abstr. 15:1989;466.7.
224. Mayfield R. D., Randall P. K., Spirduso W. W., Wilcox R. E. Selective D1 and D2 dopamine receptor antagonists produce differential effects on reaction time in the rat. Pharmac. Biochem. Behav. 46:1993;759-768.
225. McGeer P. L., McGeer E. G. Neurotransmitters and their receptors in the basal ganglia. Adv. Neurol. 60:1993;93-101.
226. McGeorge A. J., Faull R. L. M. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience. 29:1989;503-537.
227. McPherson R. J., Marshall J. F. Intrastriatal AP5 differentially affects behaviors induced by local infusions of D-1 vs D-2 dopamine agonists. Brain Res. 739:1996;19-25.
228. Mehta A. K., Ticku M. K. Role of NMDA receptors in experimental catalepsy in rats. Life Sci. 46:1990;37-42.
229. Meltzer H. Y., Young M., Metz J., Fang V. S., Schyve P. M., Arora R. C. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J. Neural. Transm. 45:1979;165-175.
230. Mink J. W. The basal ganglia: focused selection and inhibition of competing motor programs. Progr. Neurobiol. 50:1996;381-425.
231. Mink J. W., Thach W. T. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes. J. Neurophysiol. 65:1991;273-300.
232. Mink J. W., Thach W. T. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters. J. Neurophysiol. 65:1991;301-329.
233. Mink J. W., Thach W. T. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. J. Neurophysiol. 65:1991;330-350.
234. Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D., Sambrook M. A., Crossman A. R. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroscience. 32:1989;213-226.
235. Miwa H., Fuwa T., Yokochi M., Nishi K., Mizuno Y. Injection of a GABA antagonist into the mesopontine reticular formation abolishes haloperidol-induced catalepsy in rats. Neuroreport. 7:1996;2475-2478.
236. Mogenson G. J., Jones D. L., Yim C. Y. From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol. 14:1980;69-97.
237. Moghaddam B., Bunney B. S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 54:1990;1755-1760.
238. Montaron M.-F., Fabre-Thorpe M. Effect of lesioning the nucleus accumbens on attentive preparation and performance of a reaching movement in the cat. Behav. Brain Res. 79:1996;31-40.
239. Morelli M., Di Chiara G. Catalepsy induced by SCH 23390 in rats. Eur. J. Pharmac. 117:1985;179-185.
240. 2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur. J. Pharmac. 182:1990;611-612.
241. Morelli M., Fenu S., Dichiara G. Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson-differential role of D-1 and D-2 receptors. Neurochem. Int. 20:1992;261-264.
242. 2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J. Neurosci. 16:1996;605-611.
243. Moriizumi T., Hattori T. Separate neuronal populations of the rat globus pallidus projecting to the subthalamic nucleus, auditory cortex and pedunculopontine tegmental area. Neuroscience. 46:1992;701-710.
244. Muir J. L., Everitt B. J., Robbins T. W. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology (Berlin). 118:1995;82-92.
245. Nagy J. I., Carter D. A., Fibiger H. C. Anterior striatal projections to the globus pallidus, entopeduncular nucleus and substantia nigra in the rat: the GABA connection. Brain Res. 158:1978;15-29.
246. Naito A., Kita H. The cortico-pallidal projection in the rat: an anterograde tracing study with biotinylated dextran amine. Brain Res. 653:1994;251-257.
247. Nakanishi H., Kita H., Kitai S. T. Intracellular study of rat substantia nigra pars reticulata neurons in an in vitro slice preparation: electrical membrane properties and response characteristics to subthalamic stimulation. Brain Res. 437:1987;45-55.
248. Nambu A., Yoshida S. I., Jinnai K. Discharge patterns of pallidal neurons with input from various cortical areas during movement in the monkey. Brain Res. 519:1990;183-191.
249. Nauta H. J. W. Projections of the pallidal complex: an autoradiographic study in the cat. Neuroscience. 4:1979;1853-1873.
250. Neafsey E. J., Hull C. D., Buchwald N. A. Preparation for movement in the cat. II. Unit activity in the basal ganglia and thalamus. Electroencephalogr. Clin. Neurophysiol. 44:1978;714-723.
251. Nicholas A. P., Pieribone V., Hökfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. Comp. Neurol. 328:1993;575-594.
252. Nicholas A. P., Hökfelt T., Pieribone V. A. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmac. Sci. 17:1996;245-255.
253. Nieuwenhuys, R. (1985) Chemoarchitecture of the Brain. Springer Verlag, Berlin.
254. Nisenbaum L. K., Kitai S. T., Gerfen C. R. Dopaminergic and muscarine regulation of striatal enkephalin and substance p messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine. Neuroscience. 63:1994;435-449.
255. Oertel W. H., Mugnaini E. Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci. Lett. 47:1984;233-238.
256. Ögren S. O., Fuxe K. D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways. Neurosci. Lett. 85:1988;333-338.
257. Olsson M., Nikkhah G., Bentlage C., Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:1995;3863-3875.
258. Oorschot D. E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J. Comp. Neurol. 366:1996;580-599.
259. Ossowska K. The role of excitatory amino acids in experimental models of Parkinson's disease. J. Neural. Transm. 8:1994;39.
260. Ossowska K., Smialowska M., Wolfarth S. A biphasic influence of globus pallidus lesions: spontaneous catalepsy followed by anticataleptic effect. Pharmac. Biochem. Behav. 19:1983;169-176.
261. Ossowska K., Wedzony K., Wolfarth S. The role of the GABA mechanisms of the globus pallidus in mediating catalepsy, stereotypy and locomotor activity. Pharmac. Biochem. Behav. 21:1984;825-831.
262. Papa S. M., Engber T. M., Boldry R. C., Chase T. N. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists. Eur. J. Pharmac. 232:1993;247-253.
263. Parashos S. A., Marin C., Chase T. N. Synergy between a selective D1 agonist and a selective D2 antagonist in the induction of catalepsy. Neurosci. Lett. 105:1989;169-173.
264. Parent A., Hazrati L.-N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20:1995;128-154.
265. Parent A., Smith Y. Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods. Brain Res. 436:1987;296-310.
266. 2 receptor subtypes in the rat striatum: modulation of reaction time performance. J. Psychopharmac. S172.
267. Pycock C. Noradrenergic influences on dopamine-dependent behaviour in rats. Br. J. Pharmac. 57:1976;424.
268. Pycock C., Horton R. W., Marsden C. D. The behavioural effects of manipulating GABA function in the globus pallidus. Brain Res. 116:1976;353-359.
269. Pycock C. J., Dawbarn D. Acute motor effects of N-methyl-D-aspartatic acid and kainic acid applied focally to mesencephalic dopamine cell body regions in the rat. Neurosci. Lett. 18:1980;85-90.
270. Reisine T. D., Chesselet M. F., Lubetzki C., Chéramy A., Glowinski J. A role for striatal beta-adrenergic receptors in the regulation of dopamine release. Brain Res. 241:1982;123-130.
271. Richardson P. J., Kase H., Jenner P. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmac. Sci. 18:1997;338-344.
272. Richfield E. K., Young A. B., Penney J. B. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J. Comp. Neurol. 262:1987;446-463.
273. Robbins T. W., Brown V. J. The role of the striatum in the mental chronometry of action: a theoretical review. Rev. Neurosci. 2:1990;181-213.
274. Robertson H. A. Dopamine receptor interactions: some implications for the treatment of Parkinson's disease. Trends Neurosci. 15:1992;201-205.
275. Robertson H. A. Synergistic interactions of D1-selective and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias. Can. J. Neurol. Sci. 19:1992;147-152.
276. Robertson R. G., Farmery S. M., Sambrook M. A., Crossman A. R. Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus. Brain Res. 476:1989;317-322.
277. Robledo P., Féger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res. 518:1990;47-54.
278. Rogawski M. A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmac. Sci. 14:1993;325-331.
279. Romo R., Schultz W. Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. J. Neurophysiol. 63:1990;592-606.
280. Rückert N., Bubser M., Schmidt W. J. 6-Hydroxydopamine lesion of locus coeruleus and the antiparkinsonian potential of NMDA-receptor antagonists in rats. J. Neural. Transm. 104:1997;363-377.
281. Ryan L. J., Clark K. B. The role of the subthalamic nucleus in the response of globus pallidus neurons to stimulation of the prelimbic and agranular frontal cortices in rats. Exp. Brain Res. 86:1991;641-651.
282. Salamone J. D. Complex motor and sensorimotor functions of striatal and accumbens dopamine. Psychopharmacology. 107:1992;160-174.
283. Salamone J. D., Kurth P. A., McCullough L. D., Sokolowski J. D., Cousins M. S. The role of brain dopamine in response initiation-effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain Res. 628:1993;218-226.
284. Scatton B., Worms P., Lloyd K. G., Bartholini G. Cortical modulation of striatal function. Brain Res. 232:1982;331-343.
285. Scheel-Krüger, J. (1985) New aspects on the functional role of acetylcholine in the basal ganglia system. In: Central Cholinergic Mechansims and Adaptive Functions. Eds. M. M. Singh, D. M. Warburton and H. Lal. Plenum Press, New York.
286. Scheel-Krüger J. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol. Scand. 73:1986;1-54.
287. Scheel-Krüger, J. and Arnt, J. (1985) New aspects on the role of dopamine, acetylcholine, and GABA in the development of tardive dyskinesia. In: Dyskinesia - Research and Treatment. Eds. T. Casey, T. Chase, H. Christensen and M. Gerlach. Springer Verlag, Berlin.
288. Scheel-Krüger J., Magelund G. GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions. Life Sci. 29:1981;1555-1562.
289. Scheel-Krüger, J., Arnt, J., Braestrup, C., Christensen, A. V. and Magelund, G. (1979) Development of New Animal Models for GABA-ergic Actions using Muscimol as a Tool. Academic Press, Copenhagen.
290. Scheel-Krüger J., Arnt J., Magelund G., Olianas M., Przewlocka B., Christensen A. V. Behavioural functions of GABA in basal ganglia and limbic systems. Brain Res. Bull. 5:1980;261-267.
291. Scheel-Krüger, J., Magelund, G. and Olianas, M. C. (1981) Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus. In: Adv. Biochem. Psychopharmacol.: GABA and the Basal Ganglia. Eds. G. DiChiara and G. L. Gessa. Raven Press, New York.
292. Schiffmann S. N., Jacobs O., Vanderhaeghen J. J. The striatal restricted adenosine A2 receptor is expressed by enkeplalin but not by substance P neurons: an in-situ hybridization histochemistry study. J. Neurochem. 57:1991;1062-1067.
293. Schmidt, W. J. (1985) Striatal glutamic acid and behaviour. Neurosci. Lett. 22, 93.
294. Schmidt W. J. Intrastriatal injection of AP-5 induces sniffing stereotypy that is antagonized by haloperidol and clozapine. Psychopharmacology. 90:1986;123-130.
295. Schmidt, W. J. (1988) Striatale Mechanismen der Verhaltenssteuerung: Die Rolle von Dopamin, Azetylcholin und Glutamat. In: Biologische Psychiatrie. Eds H. Beckmann and G. Laux. Springer Verlag, Berlin.
296. Schmidt W. J., Bubser M. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK 801 in rats. Pharmac. Biochem. Behav. 32:1989;621-623.
297. Schmidt W. J., Kretschmer B. D. Behavioural pharmacology of glutamate receptors in the basal ganglia. Neurosci. Biobehav. Rev. 21:1997;381-392.
298. Schmidt W. J., Schmidt B., Kretschmer B. D., Hauber W. Anticataleptic potencies of glutamate antagonists. Amino Acids. 1:1991;225-237.
299. Schmidt W. J., Bubser M., Hauber W. Behavioural pharmacology of glutamate in the basal ganglia. J. Neural Transm. 38:1992;65-89.
300. Schultz W. Behavior-related activity of primate dopamine neurons. Rev. Neurol. (Paris). 150:1994;634-639.
301. Schultz W., Romo R. Dopamine neurons of the monkey midbrain: contingencies of responses to stimuli eliciting immediate behavioral reactions. J. Neurophysiol. 63:1990;607-624.
302. Schultz W., Studer A., Jonsson G., Sundström E., Mefford I. Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. Neurosci. Lett. 59:1985;225-232.
303. Schultz W., Studer A., Romo R., Sundström E., Jonsson G., Scarnati E. Deficits in reaction times and movement times as correlates of hypokinesia in monkeys with MPTP-induced striatal dopamine depletion. J. Neurophysiol. 61:1989;651-668.
304. Schwab R. S., Chafetz M. E., Walker S. Control of two simultaneous voluntary motor acts in normals and parkinsonism. Arch. Neurol. 72:1954;591-598.
305. Shammah-Lagnado S. J., Alheid G. F., Heimer L. Efferent connections of the caudal part of the globus pallidus in the rat. J. Comp. Neurol. 376:1996;489-507.
306. Sirviö J., Mazurkiewicz M., Haapalinna A., Riekkinen J. P., Lahtinen H., Riekkinen S. P. J. The effects of selective alpha-2 adrenergic agents on the performance of rats in a 5-choice serial reaction time task. Brain Res. Bull. 35:1994;451-455.
307. Skjoldager P., Fowler S. C. Effects of pimozide, across doses and within sessions, on discriminated lever release performance in rats. Psychopharmacology (Berlin). 96:1988;21-28.
308. Skjoldager P., Fowler S. C. Scopolamine attenuates the motor disruptions but not the attentional disturbances induced by haloperidol in a sustained attention task in the rat. Psychopharmacology (Berlin). 105:1991;93-100.
309. Smith Y., Bolam J. P. Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat. Brain Res. 493:1989;160-167.
310. Smith Y., Bolam J. P. The output neurones and the dopaminergic neurones of the substatia nigra receive a GABA-containing input from the globus pallidus in the rat. J. Comp. Neurol. 296:1990;47-64.
311. Smith Y., Bolam J. P. Convergence of pallidal and striatal inputs to neurones in the entopeduncular nucleus and the substantia nigra of the rat: application of a new double anterograde labeling method at electron microscopic level. Soc. Neurosci. Abstr. 16:1990;236.
312. Smith Y., Parent A. Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res. 453:1988;353-356.
313. Soghomonian J.-J., Descarries L., Watkins K. C. Serotonin innervation in adult rat neostriatum. II. Ultrastructural features: a radioautographic and immunocytochemical study. Brain Res. 481:1989;67-86.
314. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behaviour. Behav. Brain Sci. 9:1986;319-364.
315. Spirduso W. W., Abraham L. D., Wolf M. D. Effects of chlorpromazine on escape and avoidance responses: a closer look. Pharmacol. Biochem. Behav. 14:1981;433-438.
316. 3H]spiroperidol receptor binding in normal rats. Psychopharmacology. 83:1984;205-209.
317. Spirduso W. W., Gilliam P. E., Schallert T., Upchurch M., Vaughn D. M., Wilcox R. E. Reactive capacity: a sensitive behavioral marker of movement initiation and nigrostriatal dopamine function. Brain Res. 355:1985;45-54.
318. Staines W. A., Fibiger H. C. Collateral projections of neurons of the rat globus pallidus to the striatum and substantia nigra. Exp. Brain Res. 56:1984;217-220.
319. Staines W. A., Atmadja S., Fibiger H. C. Demonstration of a pallidostriatal pathway by retrograde transport of HRP-labeled lecitin. Brain Res. 206:1981;446-450.
320. 2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse. 19:1995;264-293.
321. Starr M. S., Starr B. S. Facilitation of dopamine-D1 receptor-dependent but not dopamine D(1)/D(2) receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse. Eur. J. Pharmac. 250:1993;239-246.
322. Starr M. S., Starr B. S. Glutamate antagonists modify the motor stimulant actions of D-1 and D-2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D-1/D-2 agonist apomorphine. J. Neural. Transm. 6:1993;215-226.
323. Starr M. S., Starr B. S. Comparison of the effects of NMDA and ampa antagonists on the locomotor activity induced by selective D-1 and D-2 dopamine agonists in reserpine-treated mice. Psychopharmacology. 114:1994;469-476.
324. Steckler T., Sahgal A. Psychopharmacological studies in rats responding at touch-sensitive devices. Psycho-pharmacology (Berlin). 118:1995;226-229.
325. 1 dopamine receptor-mediated responses in the striatum: Relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J. Comp. Neurol. 376:1996;530-541.
326. Sugimoto T., Hattori T., Mizuno N., Itoh K., Sato M. Direct projections from the centre median-parafascicular complex to the subthalamic nucleus in the cat and rat. J. Comp. Neurol. 214:1983;209-216.
327. Sukul N. C., Cherian L., Klemm W. R. Alpha noradrenergic agonists promote catalepsy in the mouse. Pharmac. Biochem. Behav. 31:1988;87-91.
328. Surmeier D. J., Song W.-J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16:1996;6579-6591.
329. Surmeier D. J. E. J., Wilson C. J., Cao Y., Stefani A., Kitai S. T. Dopamine Receptor Subtypes Colocalize in Rat Striatonigral Neurons. Proc. natl Acad. Sci. U.S.A. 89:1992;10178-10182.
330. Surmeier D. J. R. A., Levine M. S., Ariano M. A. Are neostriatal dopamine recptors colocalized? Trends Neurosci. 16:1993;299-305.
331. Svensson A., Pileblad E., Carlsson M. A comparison between the non-competitive NMDA antagonist dizocilpine (MK 801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice. J. Neural. Transm. 85:1991;117-129.
332. Svensson A., Carlsson A., Carlsson M. L. Differential locomotor interactions between D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. J. Neural. Transm. 90:1992;199-217.
333. Svensson A., Carlsson M. L., Carlsson A. Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice - evidence for a dual glutamatergic function with respect to psychomotor control. J. Neural. Transm. 88:1992;235-240.
334. Takada M., Nishihama M. S., Nishihama C. C., Hattori T. Two separate neuronal populations of the rat subthalamic nucleus project to the basal ganglia and pedunculopontine tegmental region. Brain Res. 442:1988;72-80.
335. Takada M., Tokuno H., Ikai Y., Mizuno N. Direct projections from the entopeduncular nucleus to the lower brainstem in the rat. J. Comp. Neurol. 342:1994;409-429.
336. Ternaux J. P., Haery F., Bourgoin S., Adrien J., Glowinski J., Hamon M. The topographical distribution of serotoninergic terminals in the neostriatum of the rat and the caudate nucleus of the cat. Brain Res. 121:1977;311-326.
337. Trouche E., Beaubaton D., Amato G., Viallet F., Legallet E. Changes in reaction time after pallidal or nigral lesion in the monkey. Adv. Neurol. 40:1984;29-38.
338. Tucci S., Fernandez R., Baptista T., Murzi E., Hernandez L. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats. Brain Res. Bull. 35:1994;125-133.
339. Van der Kooy D., Carter D. The organization of the efferent projections and striatal afferents of the entopeduncular nucleus and adjacent areas in the rat. Brain Res. 211:1981;15-36.
340. Van der Kooy D., Hattori T. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res. 186:1980;1-7.
341. Verma A., Kulkarni S. K. Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology. 107:1992;431-436.
342. Vertes R. P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313:1991;643-668.
343. Vila M., Levy R., Herrero M.-T., Ruberg M., Faucheux B., Obeso J. A., Agid Y., Hirsch E. C. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J. Neurosci. 17:1997;765-773.
344. Vincent S. R., Hökfelt T., Christensson I., Terenius L. Dynorphin-immunoreactive neurons in the central nervous system of the rat. Neurosci. Lett. 33:1982;185-190.
345. Vincent S. R., Hökfelt T., Christensson I., Terenius L. Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur. J. Pharmac. 85:1982;251-252.
346. Wadenberg M.-L. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci. Biobehav. Rev. 20:1996;325-339.
347. Waldmeier P. C., Delini-Stula A. A. Serotonin-dopamine interactions in the nigrostriatal system. Eur. J. Pharmac. 55:1979;363-373.
348. Wang J. Q., McGinty J. F. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res. 748:1997;62-70.
349. Ward R. P., Dorsa D. M. Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum. J. Comp. Neurol. 370:1996;405-414.
350. Weed M. R., Gold L. H. The effect of dopaminergic agents on reaction time in rhesus monkeys. Soc. Neurosci. Abstr. 68.6:1996;158.
351. Weick B. G., Engber T. M., Susel Z., Chase T. N., Walters J. R. Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration. Brain Res. 523:1990;16-22.
352. White L. E., Hodges H. D., Carnes K. M., Price J. L., Dubinsky J. M. Colocalization of excitatory and inhibitory neurotransmitter markers in striatal projection neurons in the rat. J. Comp. Neurol. 339:1994;328-340.
353. White I. M., Christensen J. R., Flory G. S., Miller D. W., Rebec G. V. Amphetamine, cocaine, and dizocilpine enhance performance on a lever-release, conditioned avoidance response task in rats. Psychopharmacology. 118:1995;324-331.
354. Wilcox R. E., Mudie E., Mayfield D., Young R. K., Spirduso W. W. Movement initiation characteristics in young adult rats in relation to the high- and low-affinity agonist states of the striatal D2 dopamine receptor. Brain Res. 443:1988;190-198.
355. Wilson S. A. K. Disorders of motility and muscle tone, with special reference to the striatum. Lancet. II:1925;215-268.
356. Worms P., Willigens M.-T., Continsouza-Blanc D., Lloyd K. G. The effect of different types of cortical lesions on drug-induced catalepsy in rats: a pharmacological analysis. Eur. J. Pharmac. 113:1985;53-59.
357. Wright D. E., Seroogy K. B., Lundgren K. H., Davis B. M., Jennes L. Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.
358. Yoshida M., Precht W. Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers. Brain Res. 32:1971;225-228.
359. Yoshida Y., Ono T., Kizu A., Fukushima R., Miyagishi T. Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy. Eur. J. Pharmac. 203:1991;173-180.
360. Yung K. K. L., Bolam J. P., Smith A. D., Hersch S. M., Ciliax B. J., Levey A. I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.
361. Yurek D. M., Hipkens S. B. Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior. Brain Res. 623:1993;56-64.
362. Zadow B., Schmidt W. J. The AMPA antagonists NBQX and GYKI 52466 do not counteract neurolepic-induced catalepsy. Naunyn-Schmiedberg's Arch. Pharmac. 349:1994;61-65.
363. Zadow B., Schmidt W. J. Lesions of the endopeduncular nucleus and the subthalamic nucleus reduce dopamine receptor antagonist-induced catalepsy in the rat. Behav. Brain Res. 62:1994;71-79.
364. Zigmond M. J., Berger T. W., Grace A. A., Stricker E. M. Compensatory responses to nigrostriatal bundle injury. Molec. Chem. Neuropath. 10:1989;185-200.